PortfoliosLab logo
PortfoliosLab logo
Tools
Performance Analysis
Portfolio Analysis
Factor Model
Portfolios
Lazy PortfoliosUser Portfolios
Discussions
FARN.L vs. JEPI
Performance
Risk-Adjusted Performance
Dividends
Drawdowns
Volatility

Correlation

The correlation between FARN.L and JEPI is 0.14, which is considered to be low. This implies their price changes are not closely related. A low correlation is generally favorable for portfolio diversification, as it helps to reduce overall risk by spreading it across multiple assets with different performance patterns.


-0.50.00.51.00.1

Performance

FARN.L vs. JEPI - Performance Comparison

The chart below illustrates the hypothetical performance of a $10,000 investment in Faron Pharmaceuticals Oy (FARN.L) and JPMorgan Equity Premium Income ETF (JEPI). The values are adjusted to include any dividend payments, if applicable.

-20.00%-10.00%0.00%10.00%20.00%30.00%SeptemberOctoberNovemberDecember2025February
-6.08%
5.80%
FARN.L
JEPI

Key characteristics

Sharpe Ratio

FARN.L:

0.34

JEPI:

1.67

Sortino Ratio

FARN.L:

1.26

JEPI:

2.26

Omega Ratio

FARN.L:

1.19

JEPI:

1.32

Calmar Ratio

FARN.L:

0.37

JEPI:

2.66

Martin Ratio

FARN.L:

0.95

JEPI:

8.56

Ulcer Index

FARN.L:

35.12%

JEPI:

1.53%

Daily Std Dev

FARN.L:

97.11%

JEPI:

7.84%

Max Drawdown

FARN.L:

-94.05%

JEPI:

-13.71%

Current Drawdown

FARN.L:

-80.73%

JEPI:

-0.97%

Returns By Period

In the year-to-date period, FARN.L achieves a -17.07% return, which is significantly lower than JEPI's 3.35% return.


FARN.L

YTD

-17.07%

1M

-9.33%

6M

-1.73%

1Y

36.00%

5Y*

-9.65%

10Y*

N/A

JEPI

YTD

3.35%

1M

1.00%

6M

5.80%

1Y

12.11%

5Y*

N/A

10Y*

N/A

*Annualized

Compare stocks, funds, or ETFs

Search for stocks, ETFs, and funds for a quick comparison or use the comparison tool for more options.


Risk-Adjusted Performance

FARN.L vs. JEPI — Risk-Adjusted Performance Rank

Compare risk-adjusted metric ranks to identify better-performing investments over the past 12 months.

FARN.L
The Risk-Adjusted Performance Rank of FARN.L is 6363
Overall Rank
The Sharpe Ratio Rank of FARN.L is 5959
Sharpe Ratio Rank
The Sortino Ratio Rank of FARN.L is 6666
Sortino Ratio Rank
The Omega Ratio Rank of FARN.L is 6969
Omega Ratio Rank
The Calmar Ratio Rank of FARN.L is 6363
Calmar Ratio Rank
The Martin Ratio Rank of FARN.L is 5858
Martin Ratio Rank

JEPI
The Risk-Adjusted Performance Rank of JEPI is 7272
Overall Rank
The Sharpe Ratio Rank of JEPI is 7272
Sharpe Ratio Rank
The Sortino Ratio Rank of JEPI is 6868
Sortino Ratio Rank
The Omega Ratio Rank of JEPI is 7474
Omega Ratio Rank
The Calmar Ratio Rank of JEPI is 7777
Calmar Ratio Rank
The Martin Ratio Rank of JEPI is 7070
Martin Ratio Rank
The risk-adjusted ranks indicate the investment's position relative to the market. A rank closer to 100 signifies top-performing investments, while a rank closer to 0 might suggest underperformance, based on the selected ratio. The values are calculated based on the past 12 months of returns.

FARN.L vs. JEPI - Risk-Adjusted Performance Comparison

This table presents a comparison of risk-adjusted performance metrics for Faron Pharmaceuticals Oy (FARN.L) and JPMorgan Equity Premium Income ETF (JEPI). Risk-adjusted metrics are performance indicators that assess an investment's returns in relation to its risk, enabling a more accurate comparison of different investment options.


Sharpe ratio
The chart of Sharpe ratio for FARN.L, currently valued at 0.34, compared to the broader market-2.000.002.000.341.50
The chart of Sortino ratio for FARN.L, currently valued at 1.27, compared to the broader market-4.00-2.000.002.004.006.001.272.03
The chart of Omega ratio for FARN.L, currently valued at 1.19, compared to the broader market0.501.001.502.001.191.29
The chart of Calmar ratio for FARN.L, currently valued at 0.41, compared to the broader market0.002.004.006.000.412.37
The chart of Martin ratio for FARN.L, currently valued at 0.95, compared to the broader market-10.000.0010.0020.0030.000.957.50
FARN.L
JEPI

The current FARN.L Sharpe Ratio is 0.34, which is lower than the JEPI Sharpe Ratio of 1.67. The chart below compares the historical Sharpe Ratios of FARN.L and JEPI, offering insights into how both investments have performed under varying market conditions. These values are calculated using daily returns over the previous 12 months.


Rolling 12-month Sharpe Ratio0.001.002.003.00SeptemberOctoberNovemberDecember2025February
0.34
1.50
FARN.L
JEPI

Dividends

FARN.L vs. JEPI - Dividend Comparison

FARN.L has not paid dividends to shareholders, while JEPI's dividend yield for the trailing twelve months is around 7.17%.


TTM20242023202220212020
FARN.L
Faron Pharmaceuticals Oy
0.00%0.00%0.00%0.00%0.00%0.00%
JEPI
JPMorgan Equity Premium Income ETF
7.17%7.33%8.40%11.67%6.59%5.79%

Drawdowns

FARN.L vs. JEPI - Drawdown Comparison

The maximum FARN.L drawdown since its inception was -94.05%, which is greater than JEPI's maximum drawdown of -13.71%. Use the drawdown chart below to compare losses from any high point for FARN.L and JEPI. For additional features, visit the drawdowns tool.


-80.00%-60.00%-40.00%-20.00%0.00%SeptemberOctoberNovemberDecember2025February
-67.83%
-0.97%
FARN.L
JEPI

Volatility

FARN.L vs. JEPI - Volatility Comparison

Faron Pharmaceuticals Oy (FARN.L) has a higher volatility of 17.80% compared to JPMorgan Equity Premium Income ETF (JEPI) at 1.79%. This indicates that FARN.L's price experiences larger fluctuations and is considered to be riskier than JEPI based on this measure. The chart below showcases a comparison of their rolling one-month volatility.


0.00%5.00%10.00%15.00%20.00%25.00%30.00%35.00%SeptemberOctoberNovemberDecember2025February
17.80%
1.79%
FARN.L
JEPI
PortfoliosLab logo
Performance Analysis
Portfolio AnalysisPortfolio PerformanceStock ComparisonSharpe RatioMartin RatioTreynor RatioSortino RatioOmega RatioCalmar RatioSummers Ratio
Community
Discussions


Disclaimer

The information contained herein does not constitute investment advice and made available for educational purposes only. Prices and returns on equities are listed without consideration of fees, commissions, taxes, penalties, or interest payable due to purchasing, holding, or selling.

Copyright © 2025 PortfoliosLab